Spanish medical technology startup Ainovis, founded by Pablo Menéndez, Manuel Cerezo, and Miguel Herencia, has successfully closed a new €680,000 investment round. The company was accelerated at Lanzadera in 2024
The transaction was led by Kunsen Ventures, a fund specialized in the healthtech ecosystem, and received strong backing from the medical sector. The round included internationally renowned radiologists such as Ana Canga and Luis Cerezal, as well as experts from other technology fields, including Ricardo Moya, Senior AI Technical Lead & Strategy at Telefónica Innovación Digital.
Ainovis was created to address one of the healthcare system’s most pressing bottlenecks: the growing demand for medical imaging studies combined with the limited capacity of healthcare professionals to meet that demand. The company’s vision is to equip radiology departments with virtual medical specialists capable of supporting and augmenting human professionals.
As part of this mission, Ainovis has developed Ainovis One, a Smart AI Reporting system powered by Carolina, the world’s first virtual assistant for radiologists. Carolina is capable of accurately capturing dictations, generating draft reports from minimal instructions, producing structured reports in multiple languages, detecting clinical inconsistencies, automating diagnostic test requests, and performing automatic classifications, among other functions.
The company is also developing Pablo, an advanced generative AI model expected to become the first virtual radiology resident to reach the market. Currently under development, Pablo will be able to interpret imaging studies from multiple modalities, generate automatic radiology report drafts based on its own conclusions, integrate clinical and imaging data, and answer clinical questions from healthcare professionals interactively and in real time.
Ainovis’ technological vision has been supported by the Spanish Centre for the Development of Industrial Technology and Innovation (CDTI) through its prestigious NEOTEC program. According to the company, the adoption of generative AI in radiology could significantly expand hospitals’ diagnostic capacity, reduce operational costs, shorten diagnostic waiting times, and improve the quality and efficiency of healthcare processes.
The newly raised capital will primarily be used to accelerate the commercial rollout of Ainovis One and complete the final development stages of Pablo, the Virtual Radiologist, positioning Ainovis as one of Europe’s leading companies in generative AI applied to healthcare.
“In recent years, radiology services worldwide have experienced exponential growth in imaging demand. This trend is creating an inevitable bottleneck within healthcare systems, resulting in longer waiting lists and diagnostic delays. In our view, generative AI is emerging as a strategic ally capable of optimizing clinical workflows,” said Pablo Menéndez, radiologist and co-founder of Ainovis.
Kunsen Ventures added: “Ainovis represents exactly the type of innovation we aim to support: cutting-edge technology — in this case multimodal generative AI — applied to a real and urgent healthcare challenge. The quality of the founding team and their deep technical and clinical expertise position them as leaders in this new generation of radiology reporting.”
Ainovis is a healthtech startup specialized in generative artificial intelligence applied to medical imaging diagnostics. Through its advanced virtual assistant Carolina, the platform enables radiologists to reduce reporting times by more than 20%, significantly lowering operational costs while improving standardization and diagnostic quality.
The company is driven by a multidisciplinary team combining top-level clinical expertise and advanced software engineering capabilities. Ainovis is also backed by highly competitive national programs such as NEOTEC (CDTI) and ENISA and actively collaborates in European medical innovation consortia.
cloud technology axon
With a workforce of 25 employees and operations concentrated mainly in...
